Ecto-lysophospholipase C controls lysophospholipid uptake and metabolism in porcine kidney epithelial cell line LLC-PK1

Prostaglandins and Other Lipid Mediators

Volumn 88, Issue 1-2, 2009, Pages 1-9

  Tsutsumi, Toshihiko ^a   Adachi, Mika ^b   Yoshioka, Yasuko ^b   Tokumura, Akira ^b  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Kidney epithelial cells; Lysophosphatidylcholine; Lysophospholipase C; Monoacylglycerol lipase

Indexed keywords

ESTERASE; FATTY ACID; LYSOPHOSPHOLIPASE C ENZYME; LYSOPHOSPHOLIPID; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHODIESTERASE VI; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; EPITHELIUM CELL; LIPID METABOLISM; LIPID TRANSPORT; NONHUMAN;

ANIMALS; CELL LINE; EPITHELIAL CELLS; KIDNEY; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPIDS; MASS SPECTROMETRY; SWINE; TIME FACTORS;

EID: 57649210771     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2008.08.001     Document Type: Article

References (33)

1. Soga T., Ohishi T., Matsui T., et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326 (2005) 744-751 [Erratum in: Biochem Biophys Res Commun 2005; 329: 417]
2. Torkhovskaya T.I., Ipatova O.M., Zakharova T.S., Kochetova M.M., and Khalilov E.M. Lysophospholipid receptors in cell signaling. Biochemistry (Mosc) 72 (2007) 125-131
3. Meyer zu Heringdorf D., and Jakobs K.H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 1768 (2007) 923-940
4. Murakami N., Yokomizo T., Okuno T., and Shimizu T. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. J Biol Chem 279 (2004) 42484-42491
5. Tobo M., Tomura H., Mogi C., et al. Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms. Cell Signal 19 (2007) 1745-1753
6. Obinata H., Hattori T., Nakane S., Tatei K., and Izumi T. Identification of 9- hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J Biol Chem 280 (2005) 40676-40683
7. Peter C., Waibel M., Radu C.G., et al. Migration to apoptotic "find-me" signal is mediated via the phagocyte receptor G2A. J Biol Chem 283 (2008) 5296-5305
8. Huang F., Mehat D., Predescu S., Kim K.S., and Lum H. A novel lysophospholipid-and pH-sensitive receptor, GPR4, in brain endothelial cells regulates monocyte transmigration. Endothelium 14 (2007) 25-34
9. Tokumura A. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. Biochim Biophys Acta 1582 (2002) 18-25
10. Kamanna V.S., Bassa B.V., Ganji S.H., and Roh D.D. Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease. Histol Histopathol 20 (2005) 603-613
11. Weber C.L., Frohlich J., Wang J., Hegele R.A., and Chan-Yan C. Stability of lipids on peritoneal dialysis in a patient with familial LCAT deficiency. Nephrol Dial Transplant 22 (2007) 2084-2088
12. Tokumura A., Majima E., Kariya Y., et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277 (2002) 39436-39442
13. Umezu-Goto M., Kishi Y., Taira A., et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158 (2002) 227-233
14. Ibrahim S., Langhendries J.P., Bernard A., and Tulkens P.M. Urinary phospholipids excretion in neonates treated with amikacin. Int J Clin Pharmacol Res 14 (1994) 149-156
15. Saunders D.A., Begg E.J., Kirkpatrick C.M.J., Yeo J., and Graham G.G. Measurement of total phospholipids in urine of patients treated with gentamicin. Br J Clin Pharmacol 43 (1997) 435-440
16. Baronas E.T., Lee J.W., Alden C., and Hsieh F.Y. Biomarkers to monitor drug-induced phospholipidosis. Toxicol Appl Pharmacol 218 (2007) 72-78
17. Schlondorff D., and Neuwirth R. Platelet-activating factor and the kidney. Am J Physiol 251 (1986) F1-11
18. Noris M., Perico N., Macconi D., et al. Renal metabolism and urinary excretion of platelet-activating factor in the rat. J Biol Chem 265 (1990) 19414-19419
19. Emest S., and Bello-Reuss E. Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells. J Am Soc Nephrol 10 (1999) 2306-2313
20. Tsutsumi T., Morishige J., Fukuzawa K., and Tokumura A. Movement of monoglyceride derived from hydrolysis of fluorescence-labeled lyso platelet-activating factor by lysophospholipase C through plasma membranes of porcine kidney epithelial cell line LLC-PK1. Prostaglandins Other Lipid Mediat 83 (2007) 33-41
21. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physil 37 (1959) 911-917
22. Simon M.F., Rey A., Castan-Laurel I., et al. Expression of ectolipid phosphate phosphohydrolases in 3T3F442A. Involvement in the control of lysophosphatidic acid production. J Biol Chem 277 (2002) 23131-23136
23. Tanaka M., Kishi Y., Takanezawa Y., Kakehi Y., Aoki J., and Arai H. Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS Lett 571 (2004) 197-204
24. Tokumura A., Kume T., Fukuzawa K., et al. Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity. Life Sci 80 (2007) 1641-1649
25. Sakagami H., Aoki J., Natori Y., et al. Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. J Biol Chem 280 (2005) 23084-23093
26. Nakagawa Y., Sugai M., Karasawa K., et al. Possible influence of lysophospholipase on the production of 1-acyl-2-acetylglycerophosphocholine in macrophages. Biochim Biophys Acta 1126 (1992) 277-285
27. Somma-Delpero C., Valette A., Lepetit-Thivenin J., Nobili O., Boyer J., and Verine A. Purification and properties of a monoacylglycerol lipase in human erythrocytes. Biochem J 312 (1995) 519-525
28. Muccioli G.G., Xu C., Odah E., et al. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci 27 (2007) 2883-2889
29. Karlsson M., Contreras J.A., Hellman U., Tornqvist H., and Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase; evolutionary relationship to esterases, lysophospholipase, and haloperoxidases. J Biol Chem 272 (1997) 27218-27223
30. Cao L.C., Honeyman T.W., Cooney R., Kennington L., Scheld C.R., and Jonassen J.A. Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66 (2004) 1890-1900
31. Han M.S., Park S.Y., Shinzawa K., et al. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res 49 (2008) 84-97
32. Troyer D.A., Kreisberg J.I., and Venkatachalam V. Lipid alteration in LLCPK1 cells exposed to mercuric chloride. Kidney Int 29 (1986) 530-538
33. Kanfer J.N., and McCartney D.G. GPC phosphodiesterase and phosphomonoesterase activities of renal cortex and medulla of control, antidiuresis and diuresis rats. FEBS Lett 257 (1989) 348-350